New Key Statistics Module, Z-Score and F-Score
NAS:BLRX Key Ratios
| Market Cap $ M | 40.76 |
| Enterprise Value $ M | 31.95 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.95 |
| Price/Sales | 2.23 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 17.00 |
| EPS (TTM) $ | -0.45 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | 25.90 |
| 5-y EBITDA Growth Rate % | 29.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.18 |
| EV-to-EBITDA | -1.29 |
| PEG | -- |
| Shares Outstanding M | 79.94 |
| Net Margin (%) | -176.67 |
| Operating Margin % | -204.22 |
| Pre-tax Margin (%) | -176.68 |
| Quick Ratio | 1.49 |
| Current Ratio | 1.61 |
| ROA % (ttm) | -51.59 |
| ROE % (ttm) | -202.27 |
| ROIC % (ttm) | -106.85 |
| Dividend Yield % | -- |
| Altman Z-Score | -8.77 |
BLRX Number of Guru Trades
BLRX Volume of Guru Trades
Gurus Latest Trades with NAS:BLRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BLRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BioLine Rx Ltd Insider Transactions
No Available Data
News about NAS:BLRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers